Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Juniper Pharmaceuticals adds to board of directors

Mary Ann Gray joins as audit committee chair

- PMLiVE

Dr Antoine Yver moves from AstraZeneca to Daiichi Sankyo

He becomes global head, oncology research and development

- PMLiVE

Delivering digital value

Improving outcomes, the digital responsibility

- PMLiVE

Teva and Takeda appoint head of Japanese generics venture

Hiroshi Matsumori will lead partnership of Teva’s generics portfolio and Takeda brands

- PMLiVE

Pfizer’s PCSK9 inhibitor clears another phase III trial

Bococizumab will compete with Praluent and Repatha if it reaches the market

- PMLiVE

Dr Simon Chandler joins Ora as a senior director

He brings 15 years of ophthalmic industry experience

- PMLiVE

Wearables – the technologist’s view

Patient insight is key to a successful solution

LEO expands innovation lab

Adds offices in France and Canada to new digital unit

- PMLiVE

Deal Watch February 2016

Abbott, AstraZeneca and Sanofi among those featured in this month’s roundup of pharma deal activity

- PMLiVE

Diabetes: Let’s cut the Gordian knot by Debashis Bhattacharya and Kamlesh Sheth

Digital health specialists Aegleio suggest that a culture change is needed to cope with the rise of diabetes in the UK.

Say Communications

- PMLiVE

J&J drops NGF blocker fulranumab

Says decision to return rights to Amgen based on “strategic portfolio prioritisation”

- PMLiVE

GSK gene therapy tops CHMP recommendations

ADA-SCID treatment Strimvelis set for European approval

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links